Hantavirus vaccine in 2026? at 6%
On Polymarket, "Hantavirus vaccine in 2026? " is trading at 6% YES with $119,637 in volume.
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Odds and volume are sourced live from Polymarket and refresh continuously. WyldMarkets is a discovery and research tool β we don't accept bets or hold funds.